SIRT2 and inflammatory bowel disease: Since previous studies showed that Sirt2 inhibitors are well tolerated in mice and Sirt2 knockout mice has only a very mild phenotype (16, 19, 37), targeting Sirt2 can be a safe and promising strategy to treat IBD.